Federal Judge Awards $16.8M in Pharmaceutical Patent Case (Law.com)

Federal Judge Awards $16.8M in Pharmaceutical Patent Case (Law.com)
Takeda Chemical Industries v. Mylan Laboratories, said the defendant generic drug companies acted with “exceptional misconduct and bad faith” by attempting to infringe on Takeda’s patent on a chemical compound used in the treatment of diabetes. She ordered Mylan to pay $11.4 million in fees and Alphapharm to pay $5.4 million.